Chemocentryx Weighted Average Shares Diluted Trend from 2010 to 2021

CCXI -  USA Stock  

USD 17.19  0.11  0.64%

Chemocentryx Weighted Average Shares Diluted is increasing over the last several years with slightly volatile swings. Weighted Average Shares Diluted is predicted to flatten to about 57.7 M. During the period from 2010 to 2021 Chemocentryx Weighted Average Shares Diluted regressed destribution of quarterly values had coefficient of variationof 46.42 and r-squared of  0.79. Chemocentryx Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 2.64 Million. The current Selling General and Administrative Expense is estimated to increase to about 45.5 M, while Consolidated Income is projected to decrease to (56.8 M).

Search Historical Trends 

 
Refresh
Check Chemocentryx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemocentryx main balance sheet or income statement drivers, such as Gross Profit of 54.5 M, Interest Expense of 2.9 M or Operating Expenses of 98.9 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0482, PPandE Turnover of 4.86 or Receivables Turnover of 446. Chemocentryx financial statements analysis is a perfect complement when working with Chemocentryx Valuation or Volatility modules. It can also supplement various Chemocentryx Technical models. Continue to the analysis of Chemocentryx Correlation against competitors.

Chemocentryx Quarterly Weighted Average Shares Diluted

69.79 MillionShare

Chemocentryx Weighted Average Shares Diluted Breakdown

Showing smoothed Weighted Average Shares Diluted of Chemocentryx with missing and latest data points interpolated. The weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPSDil]; determined based on the timing of issuance of shares or units in the period.Chemocentryx's Weighted Average Shares Diluted historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemocentryx's overall financial position and show how it may be relating to other accounts over time.
Weighted Average Shares Diluted10 Years Trend
Increasing
Slightly volatile
 Weighted Average Shares Diluted 
Share
      Timeline 

Chemocentryx Weighted Average Shares Diluted Regression Statistics

Arithmetic Mean 41,497,513
Geometric Mean 32,042,190
Coefficient Of Variation 46.42
Mean Deviation 13,562,401
Median 46,432,000
Standard Deviation 19,264,211
Range 61,606,352
R-Value 0.89
R-Squared 0.79
Significance 0.00010498
Slope 4,755,425

Chemocentryx Weighted Average Shares Diluted History

20114.2 M
201235.4 M
201340.9 M
201443.3 M
201543.9 M
201646.4 M
201749.6 M
201849.8 M
201956.9 M
202065.7 M
202157.7 M

About Chemocentryx Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Chemocentryx income statement, its balance sheet, and the statement of cash flows. Chemocentryx investors use historical funamental indicators, such as Chemocentryx's Weighted Average Shares Diluted, to determine how well the company is positioned to perform in the future. Although Chemocentryx investors may use each financial statement separately, they are all related. The changes in Chemocentryx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemocentryx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chemocentryx Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chemocentryx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Weighted Average Shares Diluted65.7 M57.7 M
Average Assets447.8 M483.2 M
Average Equity317.9 M343 M
Invested Capital Average323.8 M349.3 M
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chemocentryx without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to the analysis of Chemocentryx Correlation against competitors. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.